Dámaso Molero
Director Ejecutivo en 3P Biopharmaceuticals SL .
Cargos activos de Dámaso Molero
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
3P Biopharmaceuticals SL
 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Director Ejecutivo | 01/04/2007 | - |
| Presidente | 16/12/2009 | 30/01/2014 |
Historial de carrera de Dámaso Molero
Antiguos cargos conocidos de Dámaso Molero.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SHIONOGI & CO., LTD. | Corporate Officer/Principal | - | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - | - |
| Syntex, Inc. | Corporate Officer/Principal | - | - |
| Glaxo, Inc. | Corporate Officer/Principal | - | - |
Formación de Dámaso Molero.
| University of Navarra | Masters Business Admin |
Estadísticas
Internacional
| España | 3 |
| Canadá | 3 |
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| SHIONOGI & CO., LTD. | Health Technology |
| Empresas privadas | 3 |
|---|---|
3P Biopharmaceuticals SL
3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Health Technology |
| Glaxo, Inc. | |
| Syntex, Inc. | Miscellaneous |
- Bolsa de valores
- Insiders
- Dámaso Molero
- Experiencia
